首页|中药川芎嗪联合经皮肝穿瘤内注射碘油吡柔比星联合肝动脉化疗中晚期肝癌的疗效及安全性观察

中药川芎嗪联合经皮肝穿瘤内注射碘油吡柔比星联合肝动脉化疗中晚期肝癌的疗效及安全性观察

扫码查看
目的 观察中药川芎嗪联合经皮肝穿瘤内注射碘油吡柔比星联合肝动脉化疗栓塞治疗中晚期肝癌的疗效及安全性.方法 选取2012年1月~2014年9月期间,浙江省衢化医院收治的83例中晚期肝癌患者进行研究分析.采用双盲、随机的方法将所有患者分为对照组41例和观察组42例.对照组患者给予肝动脉化疗栓塞及经皮肝穿瘤内注射碘油吡柔比星联合肝动脉化疗栓塞治疗,观察组患者在对照组基础上给予中药川芎嗪治疗.结束治疗后,对2组患者的治疗疗效、不良反应及卡氏评分和凝血酶原时间进行对比分析.结果 ①在经过治疗之后,对2组患者治疗疗效进行对比分析,结果显示,观察组患者的总有效率高于对照组(χ2=4.034),差异有统计学意义(P<0.05);②对2组患者治疗后不良反应进行比较,肝区疼痛、血液毒性、发热、消化道反应患者比例相似,差异无统计学意义;③治疗后观察组甲胎蛋白(AFP)AFP<8.1ng/mL的患者比例显著高于对照组(χ2=4.338),差异有统计学意义(P<0.05);④观察组患者治疗后卡氏评分明显高于对照组,差异有统计学意义(t=7.141,P<0.05);对2组患者治疗后凝血酶原时间情况进行比较,差异无统计学意义.结论 在经皮肝穿瘤内注射碘油吡柔比星的基础上联合应用中药川穹嗪可以有效的提高治疗的疗效,且具有较好的安全性,其是一种安全且有效的治疗方法,应在临床中进行推广和使用.
Chinese medicine ligustrazine combined with percutaneous transhepatic tumor intramuscular injection of lipiodol pirarubicin combined with transhepatic arterial chemotherapy in advanced liver cancer and safety observation
Objective Observing the clinical effect of Ligustrazine Phosphate Tablets combined with percutaneous intratumoral injection of lipiodol THP on advanced hepa-tocellular carcinoma.Methods83 patients with advanced hepatocellular carcinoma from January 2012 to September 2014 were analyzed.Double-blind, randomized method All patients were divided into the control group 41 cases and observation group 42 cases.The control group were treatedwith percutaneous transhepatic intratumoral injection of lipiodol THP, the observation groupwere given Ligustrazine Phosphate Tablets combined with percutaneous intratumoral injection of lipiodol THP to treat.After treatment, the two groups of patients with treatment efficacy, adverse reactions and Karnofsky and prothrombin time were analyzed.ResultsAftertreatment, the efficacy of the two groups of patients were compared, the results showed that patients in the observation group total effective rate of the control group (χ2=4.034),the difference was statistically significant (P<0.05);two groups adverse reactions in patients after treatment were compared, liver pain, blood toxicity, fever, gastrointestinal reactions similar proportion of patients, the difference was not statistically significant;Theproportion of patients in the observation group AFP<8.1ng/mL was significantly higher (χ2=4.338), the difference was statistically significant (P<0.05);patients were observed after treatment Karnofsky score was significantly higher, the difference was statistically significant (t=7.141, P<0.05);after two groups of patients were compared prothrombin time, the difference was not statistically significant.ConclusionHepatic arterial chemoembolization and percutaneous intratumoral injection of THP lipiodol emulsion on the basis of the combination of Ligustrazine Phosphate Tablets can effectively improve the efficacy of treatment, and has good security, which is a safe and effective methods of treatment should be to promote and use in clinical.

ligustrazine phosphate tabletspercutaneous intratumoral injection of lipiodol THPradvanced liver cancerchemotherapy

郑彩霞、金情政

展开 >

浙江省衢化医院 药剂科,浙江 衢州 324004

川芎嗪 经皮肝穿瘤内注射碘油吡柔比星 中晚期肝癌 化疗

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(6)
  • 4
  • 10